Warning: The NCBI web site requires JavaScript to function. more...
A systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malaria.
Picot S, Olliaro P, de Monbrison F, Bienvenu AL, Price RN, Ringwald P.
Malar J. 2009 May 4;8:89. Review.
Related citations
Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number.
Price RN, Uhlemann AC, Brockman A, McGready R, Ashley E, Phaipun L, Patel R, Laing K, Looareesuwan S, White NJ, Nosten F, Krishna S.
Lancet. 2004 Jul 31-Aug 6;364(9432):438-47.
Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia.
Lim P, Alker AP, Khim N, Shah NK, Incardona S, Doung S, Yi P, Bouth DM, Bouchier C, Puijalon OM, Meshnick SR, Wongsrichanalai C, Fandeur T, Le Bras J, Ringwald P, Ariey F.
Malar J. 2009 Jan 12;8:11.
The usefulness of twenty-four molecular markers in predicting treatment outcome with combination therapy of amodiaquine plus sulphadoxine-pyrimethamine against falciparum malaria in Papua New Guinea.
Marfurt J, Müller I, Sie A, Oa O, Reeder JC, Smith TA, Beck HP, Genton B.
Malar J. 2008 Apr 19;7:61.
Efficacy of chloroquine, amodiaquine and sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria: revisiting molecular markers in an area of emerging AQ and SP resistance in Mali.
Tekete M, Djimde AA, Beavogui AH, Maiga H, Sagara I, Fofana B, Ouologuem D, Dama S, Kone A, Dembele D, Wele M, Dicko A, Doumbo OK.
Malar J. 2009 Feb 26;8:34.
Markers of anti-malarial drug resistance in Plasmodium falciparum isolates from Swaziland: identification of pfmdr1-86F in natural parasite isolates.
Dlamini SV, Beshir K, Sutherland CJ.
Malar J. 2010 Mar 3;9:68.
Drug resistance in Plasmodium falciparum from the Chittagong Hill Tracts, Bangladesh.
van den Broek IV, van der Wardt S, Talukder L, Chakma S, Brockman A, Nair S, Anderson TC.
Trop Med Int Health. 2004 Jun;9(6):680-7.
Plasmodium falciparum resistance to anti-malarial drugs in Papua New Guinea: evaluation of a community-based approach for the molecular monitoring of resistance.
Marfurt J, Smith TA, Hastings IM, Müller I, Sie A, Oa O, Baisor M, Reeder JC, Beck HP, Genton B.
Malar J. 2010 Jan 7;9:8.
Efficacy of antimalarial treatment in Guinea: in vivo study of two artemisinin combination therapies in Dabola and molecular markers of resistance to sulphadoxine-pyrimethamine in N'Zérékoré.
Bonnet M, Roper C, Félix M, Coulibaly L, Kankolongo GM, Guthmann JP.
Malar J. 2007 May 3;6:54.
Polymorphisms in Plasmodium falciparum dhfr and dhps genes and age related in vivo sulfadoxine-pyrimethamine resistance in malaria-infected patients from Nigeria.
Happi CT, Gbotosho GO, Folarin OA, Akinboye DO, Yusuf BO, Ebong OO, Sowunmi A, Kyle DE, Milhous W, Wirth DF, Oduola AM.
Acta Trop. 2005 Sep;95(3):183-93.
Epidemiology of drug-resistant malaria in Republic of Congo: using molecular evidence for monitoring antimalarial drug resistance combined with assessment of antimalarial drug use.
Nsimba B, Jafari-Guemouri S, Malonga DA, Mouata AM, Kiori J, Louya F, Yocka D, Malanda M, Durand R, Le Bras J.
Trop Med Int Health. 2005 Oct;10(10):1030-7.
Molecular survey of Plasmodium falciparum resistance in south-eastern Iran.
Jafari S, Le Bras J, Asmar M, Durand R.
Ann Trop Med Parasitol. 2003 Mar;97(2):119-24.
Rapid detection of Pfcrt and Pfmdr1 mutations in Plasmodium falciparum isolates by FRET and in vivo response to chloroquine among children from Osogbo, Nigeria.
Ojurongbe O, Ogungbamigbe TO, Fagbenro-Beyioku AF, Fendel R, Kremsner PG, Kun JF.
Malar J. 2007 Apr 11;6:41.
Association between mutations in Plasmodium falciparum chloroquine resistance transporter and P. falciparum multidrug resistance 1 genes and in vivo amodiaquine resistance in P. falciparum malaria-infected children in Nigeria.
Happi CT, Gbotosho GO, Folarin OA, Bolaji OM, Sowunmi A, Kyle DE, Milhous W, Wirth DF, Oduola AM.
Am J Trop Med Hyg. 2006 Jul;75(1):155-61.
Drug resistance to sulphadoxine-pyrimethamine in Plasmodium falciparum malaria in Mlimba, Tanzania.
Mbugi EV, Mutayoba BM, Malisa AL, Balthazary ST, Nyambo TB, Mshinda H.
Malar J. 2006 Oct 31;5:94.
High resistance of Plasmodium falciparum to sulphadoxine/pyrimethamine in northern Tanzania and the emergence of dhps resistance mutation at Codon 581.
Gesase S, Gosling RD, Hashim R, Ord R, Naidoo I, Madebe R, Mosha JF, Joho A, Mandia V, Mrema H, Mapunda E, Savael Z, Lemnge M, Mosha FW, Greenwood B, Roper C, Chandramohan D.
PLoS One. 2009;4(2):e4569. Epub 2009 Feb 24.
Molecular epidemiology of malaria in Cameroon. XXVII. Clinical and parasitological response to sulfadoxine-pyrimethamine treatment and Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase alleles in Cameroonian children.
Tahar R, Basco LK.
Acta Trop. 2007 Aug;103(2):81-9. Epub 2007 May 5.
Plasmodium falciparum: correlation of in vivo resistance to chloroquine and antifolates with genetic polymorphisms in isolates from the south of Lao PDR.
Berens N, Schwoebel B, Jordan S, Vanisaveth V, Phetsouvanh R, Christophel EM, Phompida S, Jelinek T.
Trop Med Int Health. 2003 Sep;8(9):775-82.
Low efficacy of chloroquine: time to switchover to artemisinin-based combination therapy for falciparum malaria in India.
Valecha N, Joshi H, Mallick PK, Sharma SK, Kumar A, Tyagi PK, Shahi B, Das MK, Nagpal BN, Dash AP.
Acta Trop. 2009 Jul;111(1):21-8. Epub 2009 Feb 7.
Plasmodium falciparum dhfr but not dhps mutations associated with sulphadoxine-pyrimethamine treatment failure and gametocyte carriage in northern Ghana.
Mockenhaupt FP, Teun Bousema J, Eggelte TA, Schreiber J, Ehrhardt S, Wassilew N, Otchwemah RN, Sauerwein RW, Bienzle U.
Trop Med Int Health. 2005 Sep;10(9):901-8.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on